X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (117) 117
oncology (111) 111
index medicus (72) 72
male (62) 62
female (61) 61
aged (57) 57
middle aged (47) 47
chemotherapy (43) 43
cancer (41) 41
aged, 80 and over (38) 38
survival (33) 33
adult (32) 32
retrospective studies (29) 29
prognosis (28) 28
care and treatment (27) 27
lung neoplasms - pathology (23) 23
neoplasm staging (23) 23
lung cancer (22) 22
hematology, oncology and palliative medicine (21) 21
treatment outcome (18) 18
lung neoplasms - drug therapy (17) 17
lung neoplasms - mortality (17) 17
respiratory system (17) 17
animals (16) 16
antineoplastic agents - therapeutic use (16) 16
non-small cell lung cancer (16) 16
phase-iii trial (16) 16
radiotherapy (16) 16
therapy (16) 16
carcinoma (15) 15
carcinoma, non-small-cell lung - pathology (15) 15
hematology (15) 15
adenocarcinoma (14) 14
expression (14) 14
surgery (14) 14
carcinoma, non-small-cell lung - mortality (13) 13
lung cancer, non-small cell (13) 13
lung neoplasms - therapy (13) 13
risk (13) 13
risk factors (13) 13
survival rate (13) 13
carcinoma, non-small-cell lung - drug therapy (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
cisplatin (11) 11
epidemiology (11) 11
article (10) 10
medicine & public health (10) 10
metastasis (10) 10
outcomes (10) 10
phase-ii trial (10) 10
research (10) 10
survival analysis (10) 10
analysis (9) 9
cell lung-cancer (9) 9
combined modality therapy (9) 9
diagnosis (9) 9
health aspects (9) 9
lung neoplasms - diagnosis (9) 9
mice (9) 9
mortality (9) 9
open-label (9) 9
pancreatic cancer (9) 9
tumors (9) 9
breast-cancer (8) 8
carboplatin (8) 8
carcinoma, non-small-cell lung - therapy (8) 8
gefitinib (8) 8
head and neck cancer (8) 8
immunohistochemistry (8) 8
internal medicine (8) 8
kaplan-meier estimate (8) 8
prophylactic cranial irradiation (8) 8
proportional hazards models (8) 8
receptor, epidermal growth factor - antagonists & inhibitors (8) 8
squamous cell carcinoma (8) 8
targeted therapy (8) 8
adolescent (7) 7
age factors (7) 7
amplification (7) 7
antibodies, monoclonal - therapeutic use (7) 7
carcinoma, squamous cell - pathology (7) 7
erlotinib (7) 7
growth-factor receptor (7) 7
lung neoplasms - metabolism (7) 7
neoplasm metastasis (7) 7
oncology, experimental (7) 7
pulmonary/respiratory (7) 7
quality of life (7) 7
smoking (7) 7
stage (7) 7
united states (7) 7
united states - epidemiology (7) 7
women (7) 7
young adult (7) 7
abridged index medicus (6) 6
age (6) 6
antineoplastic agents - pharmacology (6) 6
apoptosis (6) 6
cetuximab (6) 6
clinical trials (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 07/2014, Volume 120, Issue 13, pp. 1939 - 1947
Journal Article
Medical oncology (Northwood, London, England), 03/2018, Volume 35, Issue 4, p. 43
Anticoagulation is thought to be associated with the risk of intracranial hemorrhage (ICH) in patients with brain metastases; however, the data on this topic... 
Journal Article
Cancer Letters, ISSN 0304-3835, 08/2013, Volume 336, Issue 2, p. 270
  There is an urgent need to develop alternative therapies against lethal pancreatic cancer (PC).Ocimum sanctum("Holy Basil") has been used for thousands of... 
Studies | Rodents | Medical prognosis | Pancreatic cancer | Cytotoxicity | Metastasis | Cancer therapies | Apoptosis
Journal Article
by Cohen, Ezra E W and Cohen, Ezra and Soulières, Denis and Le Tourneau, Christophe and Dinis, Jose and Dinis, José and Licitra, Lisa and Ahn, Myung-Ju and Soria, Ainara and Machiels, Jean-Pascal and Mach, Nicolas and Mehra, Ranee and Burtness, Barbara Ann and Burtness, Barbara and Zhang, Pingye and Cheng, Jonathan and Swaby, Ramona F and Harrington, Kevin and Harrington, Kevin J and Acosta-Rivera, Mirelis and Adkins, Douglas R and Aghmesheh, Morteza and Airoldi, Mario and Aleknavicius, Eduardas and Al-Farhat, Yousuf and Algazi, Alain P and Almokadem, Salah and Alyasova, Anna and Bauman, Jessica R and Benasso, Marco and Berrocal, Alfonso and Bray, Victoria and Caponigro, Francesco and Castro, Ana and Cescon, Terrence P and Chan, Kelvin and Chaudhry, Arvind and Chauffert, Bruno and Csoszi, Tibor and De Boer, J.P and Delord, Jean-Pierre and Dietz, Andreas and Dupuis, Charlotte and Digue, Laurence and Erfan, Jozsef and Escobar Alvarez, Yolanda and Evans, Mererid and Fidler, Mary Jo and Forster, Martin David and Friesland, Signe and Ganti, Apar K and Geoffrois, Lionnel and Grant, Cliona and Gruenwald, Viktor and Hoffmann, Thomas and Horvai, Geza and Inciura, Arturas and Jang, Raymond and Jankowska, Petra and Jimeno, Antonio and Joseph, Mano and Juarez Ramiro, Alejandro and Karaszewska, Boguslawa and Kawecki, Andrzej and Keilholz, Ulrich and Keller, Ulrich and Kim, Sung-Bae and Kocsis, Judit and Kotecki, Nuria and Kozloff, Mark F and Lambea, Julio and Landherr, Laszlo and Lantsukhay, Yuri and Lazarev, Sergey Alexandrovich and Lee, Lip Way and Lifirenko, Igor Dmitrievich and Martincic, Danko and Matorin, Oleg Vladmirovhich and McGrath, Margaret and Misiukiewicz, Krzysztof and Morris, John C and Mufazalov, Fagim Fanisovich and Niu, Jiaxin and Pamoorthy Srinivasan, Devraj and Perez Segura, Pedro and Rauch, Daniel and Ribeiro, Maria Leonor and Rodriguez, Cristina and Rolland, Frederic and Russo, Antonio and Ruzsa, Agnes and Sanches, Frederico and Shin, Sang-Won and Shtiveland, Mikhail and Soulieres, Denis and Specenier, Pol and Szekanecz, Eva and Szota, Judit and van Herpen, Carla M.L and Velez-Cortes, Hector A and ... and Keynote-040 Investigators and KEYNOTE-040 investigators
The Lancet, ISSN 0140-6736, 01/2019, Volume 393, Issue 10167, pp. 156 - 167
There are few effective treatment options for patients with recurrent or metastatic head-and-neck squamous cell carcinoma. Pembrolizumab showed antitumour... 
CRITERIA | TRIAL | MEDICINE, GENERAL & INTERNAL | NIVOLUMAB | CANCER | CHEMOTHERAPY | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Docetaxel - adverse effects | Humans | Middle Aged | Squamous Cell Carcinoma of Head and Neck - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Neoplasm Recurrence, Local - drug therapy | Male | Cetuximab - therapeutic use | Cetuximab - adverse effects | Docetaxel - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Squamous Cell Carcinoma of Head and Neck - drug therapy | Female | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Head and Neck Neoplasms - drug therapy | Kaplan-Meier Estimate | Disease Progression | Head and Neck Neoplasms - pathology | Methotrexate - adverse effects | Squamous Cell Carcinoma of Head and Neck - secondary | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cetuximab - administration & dosage | Methotrexate - administration & dosage | Aged | Methotrexate | Squamous cell carcinoma | Metastasis | Therapy | Toxicity | Perforation | Clinical trials | Oncology | Cancer therapies | Metastases | Skin cancer | Anticancer properties | Pembrolizumab | Randomization | Motivation | Platinum | Neck | Safety | Medical treatment | Fatigue | Hypothyroidism | Survival | Patients | Chemotherapy | Interactive systems | Large intestine | Head and neck cancer | Ligands | Tumors
Journal Article
Cancer Letters, ISSN 0304-3835, 2012, Volume 323, Issue 1, pp. 29 - 40
Abstract Pancreatic tumors are resistant to conventional chemotherapies. The present study was aimed at evaluating the potential of a novel plant-derived... 
Hematology, Oncology and Palliative Medicine | Natural product | Therapy | Cancer metabolism | Pancreatic cancer | APOPTOSIS | GROWTH-INHIBITION | HYPOXIA | ANTITUMOR | GEMCITABINE | NECROSIS | ONCOLOGY | ANNONA-MURICATA | MUC4 MUCIN | EXPRESSION | ACETOGENINS | Pancreatic Neoplasms - metabolism | Plant Extracts - pharmacology | Humans | Blotting, Western | Necrosis | Neoplasms, Experimental - pathology | Xenograft Model Antitumor Assays | Cell Movement - drug effects | Microscopy, Confocal | Animals | Signal Transduction - drug effects | Mice, Nude | Annona - chemistry | Cell Line, Tumor | Female | Antineoplastic Agents - pharmacology | Mice | Neoplasms, Experimental - metabolism | Phytotherapy - methods | Neoplasms, Experimental - drug therapy | Real-Time Polymerase Chain Reaction | Glucose metabolism | Chemotherapy | Care and treatment | Oncology, Experimental | Physiological aspects | Metastasis | Research | Gene expression | Cells | Tumors | Cancer | Cell culture | Surgical implants | Disease | Toxicity | Clinical trials | Cytotoxicity | Cancer therapies | Protein turnover | Metastases | Cell cycle | Biocompatibility | Inhibition | Drug dosages | NF-κB protein | Cell survival | Pharmacology | Breast cancer | Tumorigenicity | Plants | Metabolism | Chemical compounds | Biological activity | Studies | Properties (attributes) | Natural products | Medical prognosis | Glycolysis | Pheochromocytoma cells | Hypoxia | Diabetes | cancer metabolism | therapy | natural product
Journal Article
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 05/2016, Issue 36, p. 176
Scientific investigation is extremely active in the treatment, management, and optimization of therapies for patients with head and neck cancer. These issues... 
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 04/2018, Volume 9, Issue 27, pp. 19396 - 19405
In contrast to other cancers, survival rates for pancreatic ductal adenocarcinoma (PDAC) patients have improved but minimally over the past thirty years. The... 
Chemotherapy | Metastasis | Survival | Pancreatic ductal adenocarcinoma | Meta-analysis
Journal Article
Medical Oncology, ISSN 1357-0560, 4/2018, Volume 35, Issue 4, pp. 1 - 7
Journal Article
Oncotarget, 03/2015, Volume 6, Issue 7, p. 5164
Journal Article